Differential metabolism of arachidonic acid in nasal polyp epithelial cells cultured from aspirin-sensitive and aspirin-tolerant patients

American Journal of Respiratory and Critical Care Medicine

Volumn 161, Issue 2 I, 2000, Pages 391-398

  Kowalski, Marek L ^a   Pawliczak, Rafal ^b   Wozniak, Janina ^b   Siuda, Katarzyna ^b   Poniatowska, Marita ^b   Iwaszkiewicz, Jolanta ^b   Kornatowski, Tomasz ^b   Kaliner, Michael A ^b  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYICOSATETRAENOIC ACID; ACETYLSALICYLIC ACID; ARACHIDONIC ACID; CALCIMYCIN; PROSTAGLANDIN F2 ALPHA;

ADULT; AGED; ARACHIDONIC ACID METABOLISM; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG SENSITIVITY; EPITHELIUM CELL; FEMALE; HUMAN; MALE; NOSE POLYP; POLYPECTOMY; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM; RHINITIS; SINUSITIS; SYMPTOMATOLOGY;

EID: 0034063822     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.161.2.9902034     Document Type: Article

References (36)

1. Samter, M., and M. F. Beers. 1968. Intolerance to aspirin: clinical studies and consideration of its pathogenesis. Ann. Intern. Med. 68:975-983.
2. Pleskow, W. W., D. D. Stevenson, D. A. Mathison, R. A. Simon, M. Schatz, and R. S. Zeiger. 1971. Aspirin-sensitive rhinosinusitis/asthma: spectrum of adverse reaction to aspirin. J. Allergy Clin. Immunol. 71: 574-579.
3. Sanak, M., H. U. Simon, and A. Szczeklik. 1997. Leukotriene C4 synthase promoter polymorphism and risk of aspirin-induced asthma. Lancet 350:1599-1600.
4. Szczeklik, A., R. J. Gryglewski, and G. Czerniawska-Mysik. 1975. Relationship of inhibition of prostaglandins biosynthesis by analgesics to asthma attacks in aspirins-sensitive patients. Br. Med. J. 1:67-69.
5. Christie, P. E., P. Tagari, A. W. Ford-Hutchinson, C. Black, A. Markendorf, M. Schmitz-Schumann, and T. H. Lee. 1992. Urinary leukotriene E4 after lysine-aspirin inhalation in asthmatic subjects. Am. Rev. Respir. Dis. 146:1531-1534.
6. Kowalski, M. L., M. Sliwinska, Y. Igarashi, M. V. White, B. Wojciechowska, P. Brayton, H. Kaulbach, J. Rozniecki, and M. A. Kaliner. 1993. Nasal secretions in response to acetylsalicylic acid. J. Allergy Clin. Immunol. 91:580-598.
7. Dahlen, B., M. Kumlin, D. J. Margolskee, C. Larsson, H. Blomqvist, V. M. Wiliams, O. Zetterstrom, and S. E. Dahlen. 1993. The leukotriene-receptor antagonist MK-0679 blocks airway obstruction induced by bronchial provocation with lysine-aspirin in aspirin-sensitive asthmatics. Eur. Respir. J. 7:1018-1026.
8. Kowalski, M. L., J. Grzegorczyk, B. Wojciechowska, and M. Poniatowska. 1996. Intranasal challenge with aspirin induces cell influx and activation of eosinophils and mast cells in nasal secretions of ASA-sensitive patients. Clin. Exp. Allergy 26:807-814.
9. Bochner, B. S., L. L. Thomas, L. Godnik, and M. Sainter. 1984. Effect of the calcium ionophore A 23187 and aspirin on histamine release in vitro from leukocytes of aspirin-intolerant donors. Int. Arch. Allergy Appl. Immunol. 74:104-107.
10. Goetzl, E. J., D. J. Valacer, D. G. Payan, and M. Y. Wong. 1986. Abnormal responses to aspirin of leukocyte oxygenation of arachidonic acid in adults with aspirin intolerance. J. Allergy Clin. Immunol. 77:693-698.
11. Nizankowska, E., Z. Michalska, M. Wandzilak, M. Radomski, E. Marcinkiewicz, R. J. Gryglewski, and A. Szczeklik. 1988. An abnormality of arachidonic acid metabolism is not a generalized phenomenon in patients with aspirin-induced asthma. Eicosanoids 1:45-48.
12. Dahlen, B., and G. Melillo. 1998. Inhalation challenge in ASA-induced asthma. Respir. Med. 92:378-384.
13. Xaubet, A., J. Mullol, E. Lopez, F. J. Roca, M. Rozman, T. Carrion, J. M. Fabra, and C. Picado. 1994. Comparison of the role of nasal polyp and normal nasal mucosal ECs on in vitro eosinophil survival: mediation by GM-CSF and inhibition by dexamethasone. Clin. Exp. Allergy 24:307-317.
14. Kowalski, M. L., R. Pawliczak, J. Wozniak, K. Siuda, J. Grzegorczyk, M. Pietrzak, Z. Kozlowski, and K. Marek. 1998. Culture of human nasal epithelial cells from nasal polyps on collagen matrix. Arch. Immunol. Ther. Exp. 46:51-57.
15. Labarca, C., and K. Paigen. 1980. A simple, rapid and sensitive assay procedure. Anal. Biochem. 104:344-352.
16. Kowalski, M. L., M. Kowalewski, R. Pawliczak, G. Woszczek, and J. Grzegorczyk. 1997. Human nasal ECs cultured from nasal polyps express both cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2) mRNA. Eur. Respir. J. 10:255s.
17. Picado, C., I. Ramis, J. Rosello, J. Prat, O. Bulbena, V. Plaza, J. M. Montserrat, and E. Gelpi. 1992. Release of peptide leukotrienc into nasal secretions after local instillation of aspirin in aspirin-sensitive asthmatic patients. Am. Rev. Respir. Dis. 145:1028-1029.
18. Sladek, K., R. Dworski, J. Soja, J. R. Sheller, E. Nizankowska, J. A. Oates, and A. Szczeklik. 1994. Eicosanoids in bronchoalveolar lavage fluid of aspirin-intolerant patients with asthma after aspirin challenge. Am. J. Respir. Crit. Care Med. 149:940-946.
19. Szczeklik, A., K. Sladek, R. Dworski, E. Nizankowska, J. Soja, J. Sheller, and J. Oates. 1996. Bronchial aspirin challenge causes specific eicosanoid response in aspirin-sensitive asthmatics. Am. J. Kespir. Crit. Care Med. 154:1608-1614.
20. Yamashita, T., H. Tsuji, N. Maeda, K. Tomoda, and T. Kumazawa. 1989. Etiology of nasal polyps associated with aspirin-sensitive asthma. Rhinol. Suppl. 8:15-24.
21. Picado, C., J. C. Fernandez-Morala, M. Juan, J. Roca-Ferrer, M. Fuentes, A. Xaubet, and J. Mullol. 1999. Cyclooxygenase-2 mRNA is downexpressed in nasal polyps from aspirin-sensitive asthmatics. Am. J. Respir. Crit. Care Med. 160:291-296.
22. Schafer, D., U. Lindenthal, M. Wagner, P. L. Bolcskei, and H. W. Baenkler. 1996. Effect of prostaglandin E2 on eicosanoid release by human bronchial biopsy specimens from normal and inflamed mucosa. Thorax 51:919-923.
23. Szczeklik, A., L. Mastalerz, E. Nizankowska, and A. Cmiel. 1996. Protective and bronchodilator effects of prostaglandin E and salbutamol in aspirin-induced asthma. Am. J. Respir. Crit. Care Med. 153:567-571.
24. Szczeklik, A., R. J. Gryglewski, E. Olszewski, A. Dembinska-Kiec, and G. Czerniawska-Mysik. 1977. Aspirin-sensitive asthma - the effect of aspirin on the release of prostaglandins from nasal polyps. Pharm. Res. Comm. 9:415-425.
25. Pawliczak, R., M. L. Kowalski, P. Kordek, and B. Bienkiewicz, 1999. The severity of chronic rhinosinusitis in aspirin-sensitive and aspirin-tolerant patients - a computed tomography assessment. Allergy 54:33.
26. Wilborn, J., L. J. Crofford, M. D. Burdick, S. L. Kunkel, R. M. Strieter, and M. Peters-Golden. 1995. Cultured lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis have a diminished capacity to synthesize prostaglandin E2 and to express cyclooxygenase-2. J. Clin. Invest. 95:1861-1868.
27. Jung, T. T., S. K. Juhn, D. Hwang, and R. Stewart. 1987. Prostaglandins, leukotrienes, and other arachidonic acid metabolites in nasal polyps and nasal mucosa. Laryngoscope 97:184-189.
28. Pinto, S., O. Gallo, G. Polli, S. Boccuzzi, R. Paniccia, T. Brunelli, and R. Abbate. 1997. Cyclooxygenase and lipoxygenase metabolite generation in nasal polyps. Prostaglandins Leukot. Essent. Fatty Acids 57:533-537.
29. Philips, M. J., W. M. Gold, and R. Goetz. 1983. IgE dependent and ionophore induced generation of leukotriene by dog mastocyloma cells. J. Immunol. 131:906-910.
30. Lai, C. K. W., J. R. Phillips, J. R. Jenkins, and S. T. Holgate. 1990. The effect of inhaled 15-(S)-hydroxyeicosatetraenoic acid (15-HETE) on airway caliber and non-specific responsivcness in normal and asthmatic subjects. Eur. Respir. Dis. 3:38-45.
31. Dahlen, S.-E., J. Raud, C. N. Serhan, J. Bjork, and B. Samuelsson. 1987. Biological activities of lipoxin A include lung strip contraction and dilation of arterioles in vivo. Acta Physiol. Scand. Suppl. 130:643-647.
32. Kumlin, M., M. Hamberg, E. Granstrom, T. Bjorck, B. Dahlen, H. Matsuda, O. Zetterstrom, and S.-E. Dahlen. 1990. 15(S)-hydroxyeicosatetraenoic acid is the major arachidonic acid metabolite in human bronchi: association with human epithelium. Arch. Biochem. Biophys. 282:254-262.
33. Hunter, J. A., W. E. Finkbeiner, J. A. Nadel, E. J. Goetzl, and M. J. Holtzman. 1985. Predominant generation of 15-lipoxygenase metabolites of arachidonic acid by ECs from human trachea. Proc. Natl. Acad. Sci. U.S.A. 82:4633-4637.
34. Shannon, V. R., P. Chanez, J. Bousquet, and M. J. Holtzman. 1993. Histochemical evidence for induction of arachidonate 15-lipoxygenase in airway disease. Am. Rev. Respir. Dis. 147:1024-1028.
35. Szczeklik, A. 1997. Mechanism of aspirin-induced asthma. Allergy 52:613-619.
36. Lecomte, M., O. Laneuville, C. Ji, D. L. de Witt, and W. L. Smith. 1994. Acetylation of human prostaglandin endoperoxide synthase-2 (cyclooxygenase-2) by aspirin. J. Biol. Chem. 269:13207-13215.